(Q45050594)
Statements
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes (English)
Geoff Hale
Evy Vandemeulebroucke
Peppy Rebello
William J Jusko
Emma Bolam
Annette-G Ziegler
Lucienne Chatenoud
10 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference